Company is awaiting regulatory approvals for several new launches targeted at improving surgical outcomes and expanding ...

Alcon Inc.'s strong growth, strategic acquisitions, and market leadership highlight its long-term potential. Read more on ALC ...

Alcon introduced the Clareon PanOptix Pro trifocal IOL, which will be commercially available in the U.S. in May, for patients with cataracts, according to a press release.The IOL is designed to ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on GeoVax Labs (GOVX – Research Report), Tango ...

Eye care company Alcon Inc., which has a major presence in North Texas, plans to buy Lensar Inc. in a deal valued up to $430 million. Orlando-based Lensar (Nasdaq: LNSR) is a laser cataract ...

GENEVA, Switzerland & ORLANDO, Fla., March 24, 2025--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and LENSAR, Inc. (NASDAQ ...

Fast-tracked cross-appeals in Delaware by Alcon Research LLC and Aurion Biotech Inc. have been closed, now that Alcon has bought a majority stake in the company that’s developing a potentially ...